Security key
52187K200
CUSIP: 52187K200
Security key
52187K200
Report period
Q4 2024
Institutions
57
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Rank 1 holder
Rank 2 holder
Rank 3 holder
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BeOne Medicines Ltd. |
3/4/5
13D/G
10%+ Owner · BeiGene, Ltd.
|
2%
from 13D/G
|
$20,943,045
7,348,437 shares
|
— | 24 Sep 2021 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
5.1%
|
$7,928,717
3,085,104 shares
|
— | 30 Sep 2024 |
| Samsara BioCapital, LLC |
13F
Company
|
4%
|
$6,276,845
2,442,352 shares
|
— | 30 Sep 2024 |
| 683 Capital Management, LLC |
13F
Company
|
2.3%
|
$3,547,886
1,380,500 shares
|
— | 30 Sep 2024 |
| Rock Springs Capital Management LP |
13F
Company
|
2.1%
|
$3,255,023
1,266,546 shares
|
— | 30 Sep 2024 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
1.9%
|
$3,012,490
1,172,175 shares
|
— | 30 Sep 2024 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Investor-level positions for this CUSIP, loaded as an interactive table.
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).